Clinical and Experimental Medicine

, Volume 13, Issue 3, pp 193–199

Resveratrol prevents TNFα-induced suppression of adiponectin expression via PPARγ activation in 3T3-L1 adipocytes

Authors

    • Department of Geriatrics, The First Affiliated HospitalChina Medical University
  • Zhen-Xian Du
    • Department of Endocrinology and Metabolism, The First Affiliated HospitalChina Medical University
  • Xin Meng
    • Department of Biochemistry and Molecular BiologyChina Medical University
Original Article

DOI: 10.1007/s10238-012-0189-2

Cite this article as:
Zhang, H., Du, Z. & Meng, X. Clin Exp Med (2013) 13: 193. doi:10.1007/s10238-012-0189-2

Abstract

Tumor necrosis factor α (TNFα) is an adipokine, whose increase is known to suppress the expression and secretion of adiponectin in adipocytes. Resveratrol has been ever reported to recover the suppression of adiponectin by TNFα, but the underlying mechanism remains poorly understood. In this study, we validated the roles of resveratrol in the inhibition of the adiponectin by TNFα in 3T3-L1 cells. Exposure to TNFα for 24 h inhibited adiponectin synthesis and secretion, but the inhibitions were partially recovered by resveratrol treatment in 3T3-L1 adipocytes. Furthermore, we found that resveratrol improved the expression of adiponectin by the increase of PPARγ DNA-binding activity. Our results suggest that resveratrol may attenuate the inhibition of adiponectin expression by TNFα via activation of PPARγ, thereby possibly improving insulin resistance. However, significant preventive effects of resveratrol were only observed when it was administrated before TNFα increase, limiting its use as preventive strategy for insulin resistance.

Keywords

ResveratrolTNFαAdiponectinPPARγAdipocyte

Copyright information

© Springer-Verlag 2012